accountAbbott Labs reported a 50% spike in second-quarter profit, helped by a tax gain, while revenue rose 9% on a weaker dollar and continued sales growth for the drug Humira.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott Net Rises 50%
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account